Welpan vet. 5 mg/ml+15 mg/ml Oral suspension
Welpan vet. 5 mg/ml+15 mg/ml Oral suspension
Authorised
- Febantel
- Pyrantel embonate
Product identification
Medicine name:
Welpan vet. 5 mg/ml+15 mg/ml Oral suspension
Active substance:
- Febantel
- Pyrantel embonate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Febantel15.00/milligram(s)1.00millilitre(s)
-
Pyrantel embonate14.40/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC55
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Tamro AB
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 13150
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 26/04/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?:
